143 related articles for article (PubMed ID: 6804109)
1. Comparison of the antianginal efficacy of acebutolol and propranolol. A multicenter, randomized, double-blind placebo-controlled study.
DiBianco R; Singh SN; Shah PM; Newton GC; Miller RR; Nahormek P; Costello RB; Laddu AR; Gottdiener JS; Fletcher RD
Circulation; 1982 Jun; 65(6):1119-28. PubMed ID: 6804109
[No Abstract] [Full Text] [Related]
2. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol.
Lee G; DeMaria AN; Favrot L; Hermanovich J; Kozina J; Krieg P; Kimchi A; Laddu A; Mason DT
J Clin Pharmacol; 1982; 22(8-9):371-8. PubMed ID: 6813360
[TBL] [Abstract][Full Text] [Related]
4. Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.
Miller NE; Nanjee MN; Rajput-Williams J; Coltart DJ
Am Heart J; 1987 Oct; 114(4 Pt 2):1007-10. PubMed ID: 3310569
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
6. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients.
Birnbaum J; DiBianco R; Becker KL; Muesing R; Costello RB; Singh SN; Gottdiener JS; Fletcher RD
Clin Pharmacol Ther; 1983 Mar; 33(3):294-300. PubMed ID: 6337762
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
Singh SN; DiBianco R; Davidov ME; Gottdiener JS; Johnson WL; Laddu AR; Fletcher RD
Circulation; 1982 Jun; 65(7):1356-64. PubMed ID: 6176357
[No Abstract] [Full Text] [Related]
8. Verapamil versus acebutolol for syndrome X.
Romeo F; Gaspardone A; Ciavolella M; Gioffrè P; Reale A
Am J Cardiol; 1988 Aug; 62(4):312-3. PubMed ID: 3041793
[No Abstract] [Full Text] [Related]
9. Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.
DiBianco R; Singh S; Singh JB; Katz RJ; Bortz R; Gottdiener JS; Spodick DH; Laddu AR; Fletcher RD
Circulation; 1980 Dec; 62(6):1179-87. PubMed ID: 6777070
[No Abstract] [Full Text] [Related]
10. Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
Higginbotham MB; Morris KG; Coleman RE; Cobb FR
Am J Cardiol; 1986 May; 57(13):1022-8. PubMed ID: 3085464
[TBL] [Abstract][Full Text] [Related]
11. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
[No Abstract] [Full Text] [Related]
12. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
14. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
[TBL] [Abstract][Full Text] [Related]
15. Effect of acebutolol and propranolol on premature ventricular complexes.
Aronow WS; Wong R; Plasencia G; Landa D; Turbow M
Clin Pharmacol Ther; 1980 Jul; 28(1):28-31. PubMed ID: 6993085
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
17. Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration.
Chaitman BR; Wagniart P; Pasternac A; Brevers G; Scholl JM; Lam J; Methe M; Ferguson RJ; Bourassa MG
Am J Cardiol; 1984 Jan; 53(1):1-9. PubMed ID: 6362383
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
Chandraratna PA
Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
[TBL] [Abstract][Full Text] [Related]
19. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
Davidov M
Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
